By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab automation company Tecan and ForteBio have partnered to integrate their liquid handling and robotics workstation technologies to provide label-free assays for use in drug discovery and bioprocess research.

The companies have worked together to integrate ForteBio's Octet 384 platform, which includes the RED 384 and the QK384, on Tecan's Freedom EVO liquid handling workstation, Tecan said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.